Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts, Malaria Journal

$ 26.00

4.8 (495) In stock

This paper examines the far-reaching implications of Triple Artemisinin-Based Combination Therapy (TACT) in the global battle against malaria. Artemisinin-Based Combination Therapy (ACT) is recognized for its cost-effectiveness, lower likelihood of adverse events, and widespread acceptance by patients and healthcare providers. However, TACT introduces novel dimensions to the fight against malaria that make them a superior choice in several aspects. TACT has been demonstrated to address resistance, offer a broader spectrum of action, reduce the risk of treatment failure, and can be tailored to meet regional needs, strengthening the global effort to combat malaria. However, maximizing these benefits of TACT depends on accessibility, particularly in resource-limited regions where malaria is most prevalent. Collaborative efforts among stakeholders, sustainable pricing strategies, efficient supply chains, and public–private partnerships are essential to ensure that TACT reaches needy populations. Moreover, dispelling prevalent malaria myths through health education campaigns is critical in this endeavour. The paper underscores the significance of collaborative initiatives and partnerships among governments, international organizations, research institutions, acadaemia, pharmaceutical companies, and local communities. Together, these efforts can pave the way for the acceptance, adoption, and success of TACT, ultimately advancing the global goal of a malaria-free world.

Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis, Malaria Journal

Antimalarial Drugs and the Control and Elimination of Malaria

Role of molecular biology. ACT, artemisinin-based combination therapy;

Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype

Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa - ScienceDirect

Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis - ScienceDirect

Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures - ScienceDirect

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype

PDF) Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency

Efficacy and Safety Assessment of Three Artemisinin-Based Combination Therapy (Acts) in the Treatment of P. falciparum Malaria in Cameroon

Enhancing the antimalarial activity of artesunate

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria, Malaria Journal